Gamma has hired Mike Hamilton as senior VP of commercial partnerships, and Casey Compernolle as VP of A&R and digital ...

GSK has announced positive headline outcomes from a Phase III trial of Blenrep with bortezomib and dexamethasone for multiple ...

This important study partially fills the gap in the knowledge of olfaction at the level of the Anterior Olfactory Nucleus (AON) and Piriform Cortex with functional magnetic resonance imaging, ...

Starwood Property Trust (STWD) came out with quarterly earnings of $0.48 per share, beating the Zacks Consensus Estimate of $0.46 per share. This compares to earnings of $0.49 per share a year ago.

An analysis of SpringWorks Therapeutics, Inc., including recent FDA approval, promising sales, and future funding for ...

Ionis Pharmaceuticals, Inc. (NASDAQ:IONS – Free Report) by 22.8% in the 3rd quarter, according to its most recent 13F filing ...

Sabra Health Care REIT, Inc. (NASDAQ:SBRA – Free Report) by 58.2% during the third quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The fund owned 875,495 ...

The information contained herein: (1) is proprietary to Morningstar and/or its content providers; (2) may not be copied or distributed; and(3) is not warranted to be accurate, complete or timely.

AnaptysBio has a past history of successes. There are 2 molecules in phase 2, but with no patient data. GSK news has hurt ANAB stock. Read more here.

All relevant comments and Gamma Communications PLC share chat regarding the GAMA LON share news are listed here in the GAMA forum. View and contribute to the GAMA share chat. Discuss Gamma ...

We asked our writers to share their best AIM-listed stocks to buy in November, featuring a Hidden Winners recommendation!